Andrea Malizia, MBA, PhD

Genova, Italy
Andrea P. Malizia is a board member and chief executive officer at Iama Therapeutics. Andrea was the director of strategy and operations at IMT School for Advanced Studies Lucca. He co-founded two strategy consulting firms, Koeus Srl, a spin-off of IMT Lucca (Italy), and QStat Consulting in the greater Boston area, focused on designing corporate and management strategies applied to competitive markets in the life science sector. Earlier in his career, he launched and served as scientific founder at BeRNA Therapeutics LLC, whose mission was to develop and deliver drugs to cure chronic pain transcutaneously. Prior he was a team leader and scientist in biologics drug discovery at Biogen. Prior to joining Biogen in 2013, he was the recipient of an NIH-T32 Ruth L. Kirschstein Institutional National Research Service Award and a research fellow in pediatrics at Harvard Medical School, Harvard University, following a Ph.D. at the University College Dublin, Ireland.
Speaking In
10:45 AM - 11:00 AM
Wednesday, June 7
IAMA Therapeutics is a Series A- late preclinical-stage pharmaceutical company focused on…
Session Room 104B